Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs
Originals
Received:
Accepted:
- 73 Downloads
- 23 Citations
Summary
The pharmacokinetics of Factor VIII was evaluated by mathematical modeling in a large-scale study in 62 haemophilia-A subjects, in whom 137 plasma Factor VIII-time curves were measured during single dose (n=87) and repeated-dose (n=47) treatments for prophylaxis or minor bleeding episodes. The pharmacokinetic parameters [mean (SD)] estimated from single-dose curves were: clearance 3.85 ml·h−1·kg−1, volume of distribution 58.2 ml·kg−1, mean residence time 15.9 h. Parameters calculated from repeated-dose curves were: clearance 3.93 ml·h−1·kg−1, volume of distribution 61.8 ml·kg−1, and half-life 12.2 h. In patients with mild haemophilia, pharmaco-statistical analysis revealed that the endogenous synthesis of Factor VIII was constant and was not influenced by the administration of exogenous Factor VIII. The coefficient of variation for intra-individual variability of Factor VIII kinetics (estimated according to the Standard Two-Stage method) was 20.7% in single-dose curves and 23.2% in repeated-dose curves.
Key words
haemophilia-A factor VIII pharmacokineticsPreview
Unable to display preview. Download preview PDF.
References
- 1.Messori A, Longo G, Matucci M, Morfini M, Rossi Ferrini P (1987) Clinical pharmacokinetics of Fctor VIII in patients with classic haemophilia. Clin Pharmacokinet 13: 365–380Google Scholar
- 2.Ruffo S, Messori A, Grasela TH, Longo G, Donati-Cori G, Matucci M, Morfini M, Tendi E (1985) A calculator program for clinical application of the Bayesian method of predicting plasma drug levels. Comput Progr Biomed 19: 167–175Google Scholar
- 3.Ruffo S, Messori A, Longo G, Matucci M, Morfini M, Rossi-Ferrini P (1986) A microcomputer program for individualizing Factor VIII dosage in hemophilia patients undergoing major surgery. Comput Progr Biomed 23: 37–46Google Scholar
- 4.Matucci M, Messori A, Donati-Cori G, Longo G, Vannini S, Morfini M, Tendi E, Rossi-Ferrini P (1985) Kinetic evaluation of four Factor VIII concentrates by model independent methods. Scand J Haematol 34: 22–28Google Scholar
- 5.Longo G, Matucci M, Messori A, Morfini M, Rossi-Ferrini P (1986) Pharmacokinetics of a new-heat treated concentrate of Factor VIII estimated by model-independent methods. Thromb Res 42: 471–476Google Scholar
- 6.Longo G, Matucci M, Morfini M, Vannini S, Messori A (1984) A calculator program for individualizing Factor VIII dosage. Drug Intell Clin Pharm 18: 726–730Google Scholar
- 7.Messori A, Longo G, Morfini M, Donati-Cori G, Matucci M, Ruffo S, Tendi E, Vannini S (1984) Individualization of Factor VIII dosage. J Clin Hosp Pharm 9: 95–103Google Scholar
- 8.Duncan B, Lloyd J, Lesnikowski E (1982) Successive Factor VIII doses for a haemophiliac undergoing major surgery calculated on a microcomputer. Thromb Haemost 47: 66Google Scholar
- 9.Noe D, Bell WR, Ness PM, Levin J (1986) Plasma clearance rates of coagulation Factors VIII and IX in factor-deficient individuals. Blood 67: 969–972Google Scholar
- 10.Sheiner LB, Beal SL (1983) Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetics data. J Pharmacokinet Biopharm 11: 303–319Google Scholar
- 11.Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New YorkGoogle Scholar
- 12.Messori A, Morfini M, Longo G, Matucci M (1986) Pharmacokinetic analysis of Factor VIII decay curves in hemophiliacs (Single-dose). Thromb Res 42: IGoogle Scholar
- 13.Ruffo S, Matucci M, Longo G, Morfini M, Vannini S, Messori A, Donati-Cori G, Tendi E, Valenza T, Zaccara G, Muscas GC A weighted least-squares approach for fitting to kinetic models the plasma concentration data of phenytoin and Factor VIII. Farmaco Prat 39: 211–221Google Scholar
- 14.Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9: 503–512Google Scholar
- 15.Messori A, Longo G, Matucci M (1986) A pharmacokinetic model for analyzing Factor VIII plasma levels in hemophilia patients undergoing major surgery. In: Lindgren S (ed) Progress in clinical pharmacy. Swedish Pharmaceutical Press, Stockholm, pp 185–192Google Scholar
- 16.Ingram GI (1981) Calculating the dose of Factor VIII in the management of haemophilia. Br J Haematol 48: 351–354Google Scholar
- 17.Whiting B, Kelman AW, Grevel J (1986) Population pharmacokinetics: theory and clinical application. Clin Pharmacokinet 11: 387–401Google Scholar
- 18.Smith K (1986) Pharmacokinetics of Factor IX (Letter). Blood 68: 979–980Google Scholar
- 19.Kasper CK, Boylen L, Ewing NP (1985) Hematologic management of hemophilia A for surgery. J Am Med Assoc 253: 1279–1283Google Scholar
- 20.Kitchens CS (1986) Surgery in hemophilia and related disorders. A prospective study of 100 consecutive procedures. Medicine 65: 34–45Google Scholar
- 21.Sampson JF, Hamstra R, Aldrete JA (1979) Surgical management of patients with hemophilia. Anesth Ann 58: 133–138Google Scholar
- 22.Abilgaard CF, Cornet JA, Fort E, Schulman I (1964) The invivo longevity of antihaemophilic factor (Factor VIII). Br J Haematol 10: 225–231Google Scholar
- 23.Noe DA, Bell RW, Ness PM (1986) Authors' reply. Blood 68: 980Google Scholar
- 24.Beal SL, Sheiner LB (1980) NONMEM Users guide, parts I and II. Technical report. Division of Clinical Pharmacology, University of California, San FranciscoGoogle Scholar
Copyright information
© Springer-Verlag 1988